A High-Throughput Antiviral Assay Based on a Sindbis Virus-GFP for the Discovery of Inhibitors of Alphavirus Replication
Viruses · 2026
DOI: 10.3390/v18030290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Gabriel Augusto Pires de Souza und 9 weiteren Autor:innen. Beteiligte Einrichtung: VirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium. Hauptthemen laut MEDLINE: Sindbis Virus, Antiviral Agents, High-Throughput Screening Assays, Virus Replication. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by the Belgian Federal Government for the VirusBank Platform (FOD VVVL), Belgian Federal Government.
Abstract (Originalsprache)
The re-emergence of alphaviruses (family Togaviridae), such as chikungunya virus, poses significant public health risks, with direct impact on quality of life and work productivity. There are no approved antiviral drugs for the treatment of infections with alphaviruses. Several alphaviruses are classified as risk group 3 agents which require handling in high-containment laboratories. To facilitate antiviral screening efforts against alphaviruses, we established a high-throughput antiviral screening assay using reporter Sindbis virus [SINV-GFP; expresses the green fluorescent protein] as a surrogate model for more pathogenic alphaviruses. The assay has strong reproducibility and was validated by reference small-molecule antivirals with various mechanisms of action. The use of high-content imaging as a readout, as demonstrated here, allows for high-throughput antiviral screening and provides a tool for early-stage antiviral discovery against emerging alphavirus threats at a lower biosafety level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- VirusBank Platform, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3001 Leuven, Belgium.
- Virology, Antiviral Drug & Vaccine Research Group, Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium.
- Centre for Drug Design and Discovery (CD3), Bio-Incubator 2, Gaston Geenslaan 2, 3001 Leuven, Belgium.
ORCID-Profile: Gabriel Augusto Pires de Souza, Rana Abdelnabi, Bert Vanmechelen, Aleksandra Siekierska, Koert Stittelaar, Johan Neyts
Förderung
- This work was supported by the Belgian Federal Government for the VirusBank Platform (FOD VVVL)
- Belgian Federal Government
Zitieren
APA
Pires de Souza, G. A., Abdelnabi, R., Vanmechelen, B., Van Eyck, L., Cloet, N., Öner, D., Roymans, D., Siekierska, A., Stittelaar, K., & Neyts, J. (2026). A High-Throughput Antiviral Assay Based on a Sindbis Virus-GFP for the Discovery of Inhibitors of Alphavirus Replication. Viruses. https://doi.org/10.3390/v18030290
Vancouver
Pires de Souza GA, Abdelnabi R, Vanmechelen B, Van Eyck L, Cloet N, Öner D, et al. A High-Throughput Antiviral Assay Based on a Sindbis Virus-GFP for the Discovery of Inhibitors of Alphavirus Replication. Viruses. 2026. doi:10.3390/v18030290
BibTeX
@article{PiresdeSouza2026,
author = {Pires de Souza, Gabriel Augusto and Abdelnabi, Rana and Vanmechelen, Bert and Van Eyck, Leni and Cloet, Nelleke and Öner, Deniz and Roymans, Dirk and Siekierska, Aleksandra and Stittelaar, Koert and Neyts, Johan},
title = {A High-Throughput Antiviral Assay Based on a Sindbis Virus-GFP for the Discovery of Inhibitors of Alphavirus Replication},
journal = {Viruses},
year = {2026},
doi = {10.3390/v18030290}
}
EUVIMED